Market Research Logo

OSANG Healthcare Co Ltd (036220) - Product Pipeline Analysis, 2017 Update

Summary

OSANG Healthcare Co Ltd (OSANG), formerly Infopia Co Ltd is a medical device company that designs, develops and distributes diagnostic biosensors for heart disease and cancers and remote diagnosing systems. The company offers diagnostic biosensors for blood glucose, hemoglobin A1c, cholesterol, immuno diagnosis, molecular diagnosis, and others. Its products comprise easygluco, element multi, healthpro, evolution, selexon, lipidpro, glucolab, clover A1c, myhealthpoint, veinprobe and gluconnect, among others. OSANG conducts research and development to develop new products. The company caters its products to diabetic markets. It distributes its products across the US, Germany, South Africa, Brazil, China, Chile, Mexico, Greece, the Netherlands, Australia, India, and others. OSANG is headquartered in Anyang, South Korea.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company OSANG Healthcare Co Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


OSANG Healthcare Co Ltd Company Overview
OSANG Healthcare Co Ltd Company Snapshot
OSANG Healthcare Co Ltd Pipeline Products and Ongoing Clinical Trials Overview
OSANG Healthcare Co Ltd – Pipeline Analysis Overview
OSANG Healthcare Co Ltd - Key Facts
OSANG Healthcare Co Ltd - Major Products and Services
OSANG Healthcare Co Ltd Pipeline Products by Development Stage
OSANG Healthcare Co Ltd Pipeline Products Overview
GeneFinder MRSA Real Amp Kit
GeneFinder MRSA Real Amp Kit Product Overview
GeneFinder Parasite 8 Real Amp Kit
GeneFinder Parasite 8 Real Amp Kit Product Overview
GeneFinder STDIII (HSV1/2/UP) Real Amp Kit
GeneFinder STDIII (HSV1/2/UP) Real Amp Kit Product Overview
Non-Blood Collection Glucose Measuring System
Non-Blood Collection Glucose Measuring System Product Overview
OSANG Healthcare Co Ltd - Key Competitors
OSANG Healthcare Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Recent Developments
OSANG Healthcare Co Ltd, Recent Developments
Jan 19, 2016: PTS Diagnostics and Jant Pharmacal Corporation Jointly Resolve Pending Litigation
May 01, 2013: Infopia Secures KRW13.34 Billion Contract To Supply Blood Glucose Measurement Bio Sensors
May 20, 2008: Infopia, Applied LipidPro System To KFDA(Korea Food & Drug Association)
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
OSANG Healthcare Co Ltd Pipeline Products and Ongoing Clinical Trials Overview
OSANG Healthcare Co Ltd Pipeline Products by Equipment Type
OSANG Healthcare Co Ltd Pipeline Products by Indication
OSANG Healthcare Co Ltd, Key Facts
OSANG Healthcare Co Ltd, Major Products and Services
OSANG Healthcare Co Ltd Number of Pipeline Products by Development Stage
OSANG Healthcare Co Ltd Pipeline Products Summary by Development Stage
GeneFinder MRSA Real Amp Kit - Product Status
GeneFinder MRSA Real Amp Kit - Product Description
GeneFinder Parasite 8 Real Amp Kit - Product Status
GeneFinder Parasite 8 Real Amp Kit - Product Description
GeneFinder STDIII (HSV1/2/UP) Real Amp Kit - Product Status
GeneFinder STDIII (HSV1/2/UP) Real Amp Kit - Product Description
Non-Blood Collection Glucose Measuring System - Product Status
Non-Blood Collection Glucose Measuring System - Product Description
OSANG Healthcare Co Ltd, Joint Venture
Glossary
List of Figures
OSANG Healthcare Co Ltd Pipeline Products by Equipment Type
OSANG Healthcare Co Ltd Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report